Qube Research & Technologies LTD Athenex, Inc. Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.24 - $1.11 $1,252 - $5,791	-5,218 Reduced 6.88%	70,638 $19,000
Q2 2022 Aug 15, 2022	BUY	$0.41 - $0.91 $31,100 - $69,028	75,856 New	75,856 $31,000
Q1 2021 May 14, 2021	SELL	$4.08 - $14.75 $85,304 - $308,393	-20,908 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$11.06 - $14.01 $195,916 - $248,173	-17,714 Reduced 45.87%	20,908 $231,000
Q3 2020 Nov 12, 2020	BUY	$10.26 - $14.55 $396,261 - $561,950	38,622 New	38,622 $467,000
Q2 2020 Aug 14, 2020	SELL	$7.11 - $13.76 $94,342 - $182,581	-13,269 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$5.71 - $15.85 $75,765 - $210,313	13,269 New	13,269 $103,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.